PubMed laboratory research record [PMID: 11595453] PubMed record related to this compound for laboratory literature review
MOTS-c is a mitochondrial-derived peptide that promotes metabolic balance, improves exercise capacity, and may aid in reducing obesity and insulin resistance
Personas con problemas digestivos, como intestino permeable, enfermedad de Crohn o sndrome del intestino irritable, que buscan favorecer la integridad intestinal
Retrieved from Hathaway, J.T., Shah, M.P., Hathaway, D.B., et al, 3rd (2024)
and Diabetes 131 (06), 34553
Originally, semaglutide was developed to treat Type 2 diabetes under the brand name Ozempic